Healthcare management and administration service company Express Scripts is scheduled to report second-quarter results on Tuesday, July 28 after market close. With shares hitting all-time highs before ...

ST. LOUIS, Dec. 3 /PRNewswire-FirstCall/ -- Express Scripts (Nasdaq: ESRX) announced it has earned URAC accreditation for Workers' Compensation Pharmacy Benefit ...

Express Scripts reported third-quarter revenue of $25.4 billion, up slightly from the $25.2 billion posted in the same quarter of 2015. So far this year, the company's revenue trails the amount ...

Shares of the top pharmacy benefits manager (PBM) Express Scripts Holding Company (NASDAQ: ESRX) rose by 15.8% in December, according to data from S&P Global Market Intelligence. The catalyst?

The Trump administration announced that the company, a pharmacy benefit manager, had agreed to make significant changes to its practices. By Rebecca Robbins and Reed Abelson Drugmakers including ...

ST. LOUIS – Express Scripts Holding Co. is looking for another chief financial officer less than a year after Cathy R. Smith joined the pharmacy benefits manager from retail giant Wal-Mart. Express ...

Berkshire Hathaway‘s 13F filings are some of the most expected filings due to Warren Buffett‘s impressive stock picking skills. Berkshire has released its filing for the third quarter earlier this ...

Express Scripts, a pharmacy benefits management company based in St. Louis, Mo., late last week disclosed it received an extortion threat in October pertaining to patient records that it holds.

Shares of the top pharmacy benefits manager (PBM) Express Scripts Holding Company (ESRX +0.00%) rose by 15.8% in December, according to data from S&P Global Market Intelligence. The catalyst?

ST. LOUIS and TAMPA, Fla., Nov. 6, 2018 /PRNewswire/ -- myMatrixx®, a leader in pharmacy services for workers' compensation programs and a subsidiary of Express Scripts Holding Company (NASDAQ: ESRX), ...

Express Scripts, the largest pharmacy benefits manager in the U.S., said on Tuesday it will partner with Imprimis Pharmaceuticals to provide a $1 alternative to Daraprim, the 62-year-old drug for a ...